Results 171 to 180 of about 51,850 (252)

Appropriate prescribing and deprescribing of proton pump inhibitors: New Choosing Wisely Canada toolkit. [PDF]

Can Fam Physician
Bland E, van Zanten SV, Thompson W.
europepmc   +1 more source

Patterns in integrative medicine usage among pediatric patients in a disorders of gut–brain interaction clinic

Journal of Pediatric Gastroenterology and Nutrition, Volume 83, Issue 2, Page 282-284, August 2026.
Austin VonAxelson, Cincinnati Children's Gastroenterology and Nutrition Research Group, Kahleb Graham, Megan Miller, Jesse Li, Hanson Ton, Emily Romantic, Kathryn Hitchcock, Rashmi Sahay, Neha Santucci   +9 more
wiley   +1 more source

Priming of labor with tafoxiparin in nulliparous term pregnant women with unripe cervix—Proof‐of‐concept and dose‐finding results from a randomized controlled trial

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 8, Page 1566-1577, August 2026.
This study shows that tafoxiparin 300 mg can increase the rate of cervical ripening and the likelihood of spontaneous onset of labor, while also reducing the duration of labor in women achieving spontaneous onset of labor. The favorable safety profile of tafoxiparin suggests suitability for routine clinical use, including home administration.
Gunvor Ekman‐Ordeberg, Maria Jonsson, Marie Blomberg, Malin Melin, Ylva Stjernholm‐Vladic, Sebastian B. Gidlöf, Dag Wide‐Swensson, Kati Tihtonen, Inge C. Olsen, Lena Degling‐Wikingsson, Per Blom, Leena Rahkonen   +11 more
wiley   +1 more source

Association of depression and gastrointestinal diseases: a three-stage study. [PDF]

Psychol Med
Zheng B, Li D, Zhu D, Yang Y, Yang H, Gao Y, Li S, Wang Y, Zhang X.   +8 more
europepmc   +1 more source

Dyspepsia and Aspirin [PDF]

BMJ, 1947
openaire   +2 more sources

Medication Burden: Beyond Counts to Recognize Polypharmacy as an Inherent Part of Living With Chronic Kidney Disease

Basic &Clinical Pharmacology &Toxicology, Volume 139, Issue 2, August 2026.
ABSTRACT Medication burden in older patients with chronic kidney disease (CKD) is substantial, and simple medication counts are insufficient for identifying those at elevated risk of inappropriate prescribing. This study characterized medication burden by assessing the number of medications, potentially inappropriate medications (PIMs) and ...
Morten Baltzer Houlind, Helle Gybel Juul‐Larsen, Charlotte Strandhave, Niels Westergaard, Anne Estrup Olesen   +4 more
wiley   +1 more source

Exploring Clinical Similarities and Distinctions Between Gastroparesis and Functional Dyspepsia: A Propensity-Matched Cohort Study. [PDF]

Neurogastroenterol Motil
Rao S, Shah V, Karkra R, Gunani M, Goyal RM, Al-Khazraji A, Hajifathalian K, Rupert AA.   +7 more
europepmc   +1 more source

Classification and Severity Assessment of Obesity in Clinical Risk Prediction of Multimorbidity Trajectories

Clinical Obesity, Volume 16, Issue 4, August 2026.
ABSTRACT Obesity is a key risk factor for chronic disease and multimorbidity, yet variation in how obesity is defined may influence risk estimation in clinical practise. Waist‐to‐hip ratio (WHR) and waist‐to‐height ratio (WHtR) are better at capturing fat distribution than body mass index (BMI) and may have a role in obesity related multimorbidity ...
Afua Ampadu‐Yeboah, Alistair Carr, Frederick Ho, Jason Gill, Naveed Sattar, Bhautesh Dinesh Jani   +5 more
wiley   +1 more source

Berberine and Metabolic Dysfunction‐Associated Steatotic Liver Disease: Hope or Hype?

Pharmacology Research &Perspectives, Volume 14, Issue 4, August 2026.
Ruth Nona, Eric Kalo
wiley   +1 more source

Insulin Sensitivity and Beta Cell Function With Macupatide Alone or With Dulaglutide in Type 2 Diabetes: A Phase 1b, Randomised Controlled Trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 7196-7206, August 2026.
ABSTRACT Aims This Phase 1b, randomised, double‐blind clinical trial investigated the contribution of glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1) to insulin sensitivity and secretion in people with type 2 diabetes (T2D) on metformin. Materials and Methods Participants were randomised to receive the long‐acting
Tim Heise, Eric Zijlstra, Andrea Mari, William C. Roell, Kieren J. Mather, Axel Haupt, Panagiotis Flevaris, Ran Liao, Laiyi Chua, Charles Harris, Edward J. Pratt   +10 more
wiley   +1 more source